These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20860742)

  • 1. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab.
    Kreft B; Wohlrab J; Bramsiepe I; Eismann R; Winkler M; Marsch WC
    J Dermatol; 2010 Oct; 37(10):904-6. PubMed ID: 20860742
    [No Abstract]   [Full Text] [Related]  

  • 2. Etoricoxib-induced toxic epidermal necrolysis.
    Moutran R; Maatouk I; Hélou J
    Int J Dermatol; 2014 Apr; 53(4):e275-7. PubMed ID: 23879726
    [No Abstract]   [Full Text] [Related]  

  • 3. A case report on toxic epidermal necrolysis with etoricoxib.
    Kameshwari JS; Devde R
    Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoricoxib-induced toxic epidermal necrolysis: A fatal case report.
    Roy SS; Mukherjee S; Era N; Mukherjee M
    Indian J Pharmacol; 2018; 50(3):139-142. PubMed ID: 30166751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric toxic epidermal necrolysis treated successfully with infliximab.
    Chafranska L; Saunte DM; Behrendt N; Nygaard U; Christensen RJ; Sand C; Jemec GB
    Pediatr Dermatol; 2019 May; 36(3):342-345. PubMed ID: 30834560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.
    Fischer M; Fiedler E; Marsch WC; Wohlrab J
    Br J Dermatol; 2002 Apr; 146(4):707-9. PubMed ID: 11966713
    [No Abstract]   [Full Text] [Related]  

  • 7. Extensive hypertrophic scarring after toxic epidermal necrolysis in a child.
    Kreft B; Lieser U; Haase R; Marsch WC; Wohlrab J
    Pediatr Dermatol; 2014; 31(4):527-8. PubMed ID: 23025572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of infliximab in toxic epidermal necrolysis: a still opened challenge.
    Ganzetti G; Campanati A; Simonetti O; Giuliodori K; Giangiacomi M; Lemme G; Offidani A
    G Ital Dermatol Venereol; 2015 Aug; 150(4):467-71. PubMed ID: 25394212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
    Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE
    Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab.
    Al-Shouli S; Abouchala N; Bogusz MJ; Al Tufail M; Thestrup-Pedersen K
    Acta Derm Venereol; 2005; 85(6):534-5. PubMed ID: 16396808
    [No Abstract]   [Full Text] [Related]  

  • 11. Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate.
    Hashim N; Bandara D; Tan E; Ilchyshyn A
    Acta Derm Venereol; 2004; 84(1):90-1. PubMed ID: 15040495
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic epidermal necrolysis in a child successfully treated with infliximab.
    Scott-Lang V; Tidman M; McKay D
    Pediatr Dermatol; 2014; 31(4):532-4. PubMed ID: 23072342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review.
    Zhang S; Tang S; Li S; Pan Y; Ding Y
    J Dermatolog Treat; 2020 Feb; 31(1):66-73. PubMed ID: 30702955
    [No Abstract]   [Full Text] [Related]  

  • 14. FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.
    Morgado-sCarrasco D; Fustà-Novell X; Iranzo P
    Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):601-603. PubMed ID: 30971332
    [No Abstract]   [Full Text] [Related]  

  • 15. Thalidomide in toxic epidermal necrolysis.
    Levy R
    Lancet; 1999 Jan; 353(9149):324. PubMed ID: 9929048
    [No Abstract]   [Full Text] [Related]  

  • 16. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Koh MJ; Tay YK
    Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid.
    Jiang YY; Nguyen GH; Jin HZ; Zeng YP
    Int J Dermatol; 2018 Apr; 57(4):494-496. PubMed ID: 29359334
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis.
    Woolridge KF; Boler PL; Lee BD
    Cutis; 2018 Jan; 101(1):E15-E21. PubMed ID: 29529123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
    Wojtkiewicz A; Wysocki M; Fortuna J; Chrupek M; Matczuk M; Koltan A
    Acta Derm Venereol; 2008; 88(4):420-1. PubMed ID: 18709327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.